Trading at 2 x EBITDA.
Forget the past NLST is about the FUTURE.Read the Seeking Alpha article.
If TPLM is $5 EOX should be at least $2.
VLTC was over $50 in 2010 but was hit hard when they lost the AT+T contract, which was 70% of revenue. VLTC added 4 major customers in 2014 and is now much more diversified.
According to the 10K, VLTC slashed costs in Q1 2015. Consequently VLTC should approach cash flow breakeven in 2015 after years of large losses. One analyst is predicting profitability for 2016.
The $50 share price in 2010 was based on anticipation of imminent profit. With profit again in sight, VLTC is poised to go much higher in anticipation IMO.
Like a prior poster said, the big boys not selling here. There buying.
Prostate cancer is treatable with surgery but unfortunately leaves many side effects because the treatment targets the entire prostate, and can cause incontinence and impotence.
SPHS has a HUGE potentlal market because it targets ONLY the cancerous area within the prostate, avoiding the side effects.
IMO a $50 million market cap ($3.50 per share) is still DIRT CHEAP for the potential market for this stock.
Best to ignore him / her.
VLTC is just starting. $5 soon.
After reading the Judges comments posted on this Board I now think the balance of probablity is that the Jury decision will be reversed. Couldn't be more clear: she said uniquevocally the jury SCREWED UP.
Never seen a company with $76 million net current assets go bankrupt.
32 sites in prime locations.